1.
Kimmel G, Chima M, Kim HJ, Bares J, Yaroshinsky A, Singer G, Kim SJ, Bagel J, Lebwohl M. Brodalumab in the treatment of moderate-to-severe psoriasis in patients refractory to anti-interleukin-17A therapies: Evaluation of secondary endpoints. J of Skin [Internet]. 2021Sep.13 [cited 2021Oct.19];5(5):524-9. Available from: https://jofskin.org/index.php/skin/article/view/1309